BNP Paribas Financial Markets’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-212,807
Closed -$2.13M 4984
2022
Q3
$2.13M Buy
+212,807
New +$2.12M ﹤0.01% 1918

BNP Paribas Financial Markets's LUXA Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 212,807 shares — an estimated $2.13M sold.

BNP Paribas Financial Markets first reported a position in LUXA in Q3 2022 and held it in 1 quarter. The position peaked at $2.13M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 212,807 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.13M.
  • BNP Paribas Financial Markets first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.13M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.